Girges, Christine http://orcid.org/0000-0001-5019-6812
Vijiaratnam, Nirosen
Athauda, Dilan
Auld, Grace
Gandhi, Sonia
Foltynie, Thomas
Article History
Accepted: 11 March 2021
First Online: 19 March 2021
Declarations
:
: No funding was received specifically for the publication of this review.
: CG reports no conflicts of interest. NV has received unconditional educational grants from IPSEN and Biogen, travel grants from IPSEN, AbbVie and The International Parkinson’s Disease and Movement Disorders Society, speaker’s honorarium from AbbVie and STADA and served on advisory boards for Abbvie and Brittania outside of the submitted work. DA has received travel grants from Bial. GA reports no conflicts of interest. SG reports no conflicts of interest. TF has received grants from National Institute of Health Research, Michael J Fox Foundation, John Black Charitable Foundation, Cure Parkinson’s Trust, Innovate UK, Van Andel Research Institute and Defeat MSA. He has served on Advisory Boards for Voyager Therapeutics, Handl therapeutics, Living Cell Technologies, Bial, and Profie Pharma. He has received honoraria for talks sponsored by Bial, Profile Pharma, and Boston Scientific.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: CG: Review of literature, preparation of manuscript, critical revision for intellectual content; NV: Interpretation of data, critical revision of manuscript for intellectual content; DA: Interpretation of data, critical revision of manuscript for intellectual content; GA: Critical revision of manuscript for intellectual content; SG: Critical revision of manuscript for intellectual content; TF: Article concept and design, interpretation of data, critical revision of manuscript for intellectual content.